These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17536975)

  • 21. Improved short-term engraftment of lentivirally versus gammaretrovirally transduced allogeneic canine repopulating cells.
    Neff T; Gerull S; Peterson LJ; Kiem HP
    J Gene Med; 2007 May; 9(5):357-61. PubMed ID: 17421055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immune reconstitution after allogeneic stem cell transplantation using nonmyeloablative or reduced-intensity conditioning regimen].
    Nakai K
    Nihon Rinsho; 2003 Sep; 61(9):1542-8. PubMed ID: 14515721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
    Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD
    Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.
    Resnick IB; Shapira MY; Slavin S
    Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human alkyltransferase-transduced murine myeloid progenitors are enriched in vivo by BCNU treatment of transplanted mice.
    Allay JA; Davis BM; Gerson SL
    Exp Hematol; 1997 Sep; 25(10):1069-76. PubMed ID: 9293904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of conditioning regimens and stem cell sources on donor-type chimerism early after stem cell transplantation.
    Sugita J; Tanaka J; Hashimoto A; Shiratori S; Yasumoto A; Wakasa K; Kikuchi M; Shigematsu A; Miura Y; Tsutsumi Y; Kondo T; Asaka M; Imamura M
    Ann Hematol; 2008 Dec; 87(12):1003-8. PubMed ID: 18636260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical relevance of recipient leukocyte infusion as antitumor therapy following nonmyeloablative allogeneic hematopoietic cell transplantation.
    Saito TI; Rubio MT; Sykes M
    Exp Hematol; 2006 Sep; 34(9):1271-7. PubMed ID: 16939820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed Hodgkin's disease following autologous stem cell transplantation.
    Ruiz-Argüelles GJ; López-Martínez B; López-Ariza B
    Arch Med Res; 2003; 34(3):242-5. PubMed ID: 14567405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of donor-type chimerism in lineage-specific cell populations after allogeneic myeloablative and non-myeloablative stem cell transplantation.
    Miura Y; Tanaka J; Toubai T; Tsutsumi Y; Kato N; Hirate D; Kaji M; Sugita J; Shigematsu A; Iwao N; Ota S; Masauzi N; Fukuhara T; Kasai M; Asaka M; Imamura M
    Bone Marrow Transplant; 2006 May; 37(9):837-43. PubMed ID: 16547484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of 1,3-bis(2-chloroethyl)-1-nitrosourea-induced severe immunodeficiency by transduction of murine long-lived hemopoietic progenitor cells using O6-methylguanine DNA methyltransferase complementary DNA.
    Maze R; Kapur R; Kelley MR; Hansen WK; Oh SY; Williams DA
    J Immunol; 1997 Jan; 158(2):1006-13. PubMed ID: 8993023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation.
    Slavin S; Morecki S; Weiss L; Or R
    J Hematother Stem Cell Res; 2002 Apr; 11(2):265-76. PubMed ID: 11983098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
    Du B; Li DP; Xu KL; Pan XY
    Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates.
    Beard BC; Trobridge GD; Ironside C; McCune JS; Adair JE; Kiem HP
    J Clin Invest; 2010 Jul; 120(7):2345-54. PubMed ID: 20551514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reproductive capability in dogs with canine leukocyte adhesion deficiency treated with nonmyeloablative conditioning prior to allogeneic hematopoietic stem cell transplantation.
    Burkholder TH; Colenda L; Tuschong LM; Starost MF; Bauer TR; Hickstein DD
    Blood; 2006 Sep; 108(5):1767-9. PubMed ID: 16645166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic therapy of human neoplastic disease.
    Deisseroth AB; Hanania EG; Fu S; Claxton D; Andreeff M; Champlin R; Kavanagh J; Hortobagyi G; Holmes F; Reading C
    J Hematother; 1993; 2(3):373-5. PubMed ID: 7921999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemoprotection in brain tumor patients: another success for stem cell gene therapy.
    Sorrentino BP
    Mol Ther; 2012 Aug; 20(8):1485-7. PubMed ID: 22850719
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetic variability in some physiological constants of dogs.
    FULLER JL
    Am J Physiol; 1951 Jul; 166(1):20-4. PubMed ID: 14857144
    [No Abstract]   [Full Text] [Related]  

  • 39. A universal system to select gene-modified hepatocytes in vivo.
    Nygaard S; Barzel A; Haft A; Major A; Finegold M; Kay MA; Grompe M
    Sci Transl Med; 2016 Jun; 8(342):342ra79. PubMed ID: 27280686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of Genetically Engineered Precursor T-Cells From Human Umbilical Cord Blood Using an Optimized Alpharetroviral Vector Platform.
    Hübner J; Hoseini SS; Suerth JD; Hoffmann D; Maluski M; Herbst J; Maul H; Ghosh A; Eiz-Vesper B; Yuan Q; Ott M; Heuser M; Schambach A; Sauer MG
    Mol Ther; 2016 Aug; 24(7):1216-26. PubMed ID: 27138041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.